Genentech nears trade secrets suit settlement with Taiwanese company but still targeting former employees

//Genentech nears trade secrets suit settlement with Taiwanese company but still targeting former employees

Genentech nears trade secrets suit settlement with Taiwanese company but still targeting former employees

Biotech powerhouse Genentech Inc. is close to settling a with a Taiwanese company that allegedly stole trade secrets and planned to launch a look-alike version of one of Genentech's most popular drugs. The settlement between the South San Francisco-based U.S. unit of drug giant Roche and JHL Biotech Inc. requires the Taiwanese company to stop development of biosimilar versions of Genentech's cancer drugs Rituxan, Herceptin and Avastin — all multibillion-dollar biologics — and the cystic fibrosis…

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2019-09-06T21:54:56+00:00 September 6th, 2019|Healthcare|

About the Author: